Raras
Buscar doenças, sintomas, genes...
Alopecia
ORPHA:79364CID-11 · ED70DOENÇA RARA

Perda de cabelo geralmente no couro cabeludo. Pode resultar em manchas calvas ou espalhar-se por todo o couro cabeludo ou toda a epiderme. Pode ser androgenética ou causada por agentes quimioterápicos, puxões compulsivos de cabelo, doenças autoimunes ou condições congênitas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Perda de cabelo geralmente no couro cabeludo. Pode resultar em manchas calvas ou espalhar-se por todo o couro cabeludo ou toda a epiderme. Pode ser androgenética ou causada por agentes quimioterápicos, puxões compulsivos de cabelo, doenças autoimunes ou condições congênitas.

Pesquisas ativas
36 ensaios
689 total registrados no ClinicalTrials.gov
Publicações científicas
25.949 artigos
Último publicado: 2026 Mar
Medicamentos
9 registrados
MINOXIDIL, RITLECITINIB TOSYLATE, FINASTERIDE

Tem tratamento?

9 medicamentos registrados
Ver detalhes, fases e interações →
MINOXIDILRITLECITINIB TOSYLATEFINASTERIDEBIMATOPROSTCLASCOTERONERUXOLITINIBUPADACITINIBHYDROCORTISONERITLECITINIB
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
53 sintomas
🦴
Ossos e articulações
19 sintomas
😀
Face
18 sintomas
👁️
Olhos
17 sintomas
🧠
Neurológico
10 sintomas
📏
Crescimento
9 sintomas

+ 89 sintomas em outras categorias

Características mais comuns

Hiperpigmentação da pele
Pelos axilares esparsos
Alopecia do couro cabeludo
Epicanto
Pescoço alado
Anormalidade da fala ou vocalização
249sintomas
Sem dados (249)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 249 características clínicas mais associadas, ordenadas por frequência.

Hiperpigmentação da peleHyperpigmentation of the skin
Pelos axilares esparsosSparse axillary hair
Alopecia do couro cabeludoAlopecia of scalp
EpicantoEpicanthus
Pescoço aladoWebbed neck

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico25.949PubMed
Últimos 10 anos200publicações
Pico2026198 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

14 genes identificados com associação a esta condição.

RPL21Large ribosomal subunit protein eL21Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688)

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasmEndoplasmic reticulum

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Hypotrichosis 12

A form of hypotrichosis, a condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The extent of scalp and body hair involvement can be very variable, within as well as between families. HYPT12 patients have normal scalp hair density at birth. Hair loss begins during the first 6 months of life and gradually progresses to nearly complete loss of scalp hair. The remaining hairs grow slowly and are thin, sparse, dry, and fragile. Body hair, axillary and pubic hair, eyebrows and eyelashes are also sparse or absent. HYPT12 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
2224.4 TPM
Linfócitos
1617.1 TPM
Cervix Ectocervix
1567.4 TPM
Cervix Endocervix
1360.3 TPM
Fallopian Tube
1351.9 TPM
OUTRAS DOENÇAS (2)
hypotrichosis 12hypotrichosis simplex
HGNC:10313UniProt:P46778
LPAR6Lysophosphatidic acid receptor 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to oleoyl-L-alpha-lysophosphatidic acid (LPA). Intracellular cAMP is involved in the receptor activation. Important for the maintenance of hair growth and texture

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
G alpha (q) signalling eventsP2Y receptors
MECANISMO DE DOENÇA

Woolly hair autosomal recessive 1 with or without hypotrichosis

A hair shaft disorder characterized by fine and tightly curled hair. Compared to normal curly hair that is observed in some populations, woolly hair grows slowly and stops growing after a few inches. Under light microscopy, woolly hair shows some structural anomalies, including trichorrhexis nodosa and tapered ends. Some individuals exhibit features of hypotrichosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Vagina
65.9 TPM
Esôfago - Mucosa
55.4 TPM
Próstata
55.2 TPM
Glândula salivar
47.4 TPM
Cervix Endocervix
39.5 TPM
OUTRAS DOENÇAS (3)
hypotrichosis 8isolated familial wooly hair disorderhypotrichosis simplex
HGNC:15520UniProt:P43657
LSSLanosterol synthaseCandidate gene tested inTolerante
FUNÇÃO

Key enzyme in the cholesterol biosynthesis pathway. Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol nucleus (PubMed:14766201, PubMed:26200341, PubMed:7639730). Through the production of lanosterol may regulate lens protein aggregation and increase transparency (PubMed:26200341)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
Lanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Cataract 44

An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
93.6 TPM
Pituitária
81.3 TPM
Ovário
81.1 TPM
Cerebelo
72.7 TPM
Cervix Ectocervix
70.7 TPM
OUTRAS DOENÇAS (7)
hypotrichosis 14alopecia-intellectual disability syndrome 4cataract 44autosomal recessive palmoplantar keratoderma and congenital alopecia
HGNC:6708UniProt:P48449
SHOC2Leucine-rich repeat protein SHOC-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates activation of the MAPK pathway (PubMed:10783161, PubMed:16630891, PubMed:25137548, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Acts as a scaffolding protein in the SMP complex (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' o

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (2)
RAF activationGain-of-function MRAS complexes activate RAF signaling
MECANISMO DE DOENÇA

Noonan syndrome-like disorder with loose anagen hair 1

A syndrome characterized by Noonan dysmorphic features such as macrocephaly, high forehead, hypertelorism, palpebral ptosis, low-set and posteriorly rotated ears, short and webbed neck, pectus anomalies, in association with pluckable, sparse, thin and slow-growing hair.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
56.1 TPM
Fibroblastos
40.3 TPM
Testículo
40.0 TPM
Artéria tibial
36.9 TPM
Tecido adiposo
36.7 TPM
OUTRAS DOENÇAS (3)
Noonan syndrome-like disorder with loose anagen hair 1RASopathyNoonan syndrome-like disorder with loose anagen hair
HGNC:15454UniProt:Q9UQ13
LIPHLipase member HDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Hydrolyzes specifically phosphatidic acid (PA) to produce 2-acyl lysophosphatidic acid (LPA; a potent bioactive lipid mediator) and fatty acid. Does not hydrolyze other phospholipids, like phosphatidylserine (PS), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) or triacylglycerol (TG)

LOCALIZAÇÃO

SecretedCell membrane

VIAS BIOLÓGICAS (1)
Synthesis of PA
MECANISMO DE DOENÇA

Hypotrichosis 7

A condition characterized by the presence of less than the normal amount of hair. Affected individuals have sparse or absent scalp, axillary and body hair and sparse eyebrows and eyelashes. HYPT7 inheritance is autosomal recessive.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Estômago
28.5 TPM
Glândula salivar
19.9 TPM
Esôfago - Mucosa
19.0 TPM
Cólon transverso
17.6 TPM
Pulmão
15.8 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
hypotrichosis 7hypotrichosis simplexisolated familial wooly hair disorder
HGNC:18483UniProt:Q8WWY8
DSC3Desmocollin-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (By similarity). Required for cell-cell adhesion in the epidermis, as a result required for the maintenance of the dermal cohesion and the dermal barrier function (PubMed:19717567). Required for cell-cell adhesion of epithelial cell layers surrounding the telogen hair club, as a result plays an important role in telogen hair shaft anchorage (By similarity). Essential for successful comple

LOCALIZAÇÃO

Cell membraneCell junction, desmosomeCytoplasm

VIAS BIOLÓGICAS (1)
Formation of the cornified envelope
MECANISMO DE DOENÇA

Hypotrichosis and recurrent skin vesicles

A disorder characterized by hypotrichosis and the appearance of recurrent skin vesicle formation. Affected individuals show sparse and fragile hair on scalp, as well as absent eyebrows and eyelashes. Vesicles filled with thin, watery fluid are observed on the scalp and skin of most of the body. Mucosal vesicles are absent.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
310.3 TPM
Skin Sun Exposed Lower leg
304.3 TPM
Esôfago - Mucosa
142.6 TPM
Vagina
100.5 TPM
Glândula salivar
13.2 TPM
OUTRAS DOENÇAS (1)
hereditary hypotrichosis with recurrent skin vesicles
HGNC:3037UniProt:Q14574
HLA-DRAHLA class II histocompatibility antigen, DR alpha chainCandidate gene tested inRestrito
FUNÇÃO

An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneEarly endosome membraneLate endosome membraneLysosome membraneAutolysosome membrane

VIAS BIOLÓGICAS (7)
Generation of second messenger moleculesTranslocation of ZAP-70 to Immunological synapsePhosphorylation of CD3 and TCR zeta chainsCo-inhibition by PD-1Downstream TCR signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
4319.6 TPM
Baço
1735.8 TPM
Pulmão
1678.3 TPM
Intestino delgado
982.9 TPM
Tecido adiposo
833.1 TPM
OUTRAS DOENÇAS (1)
Graham Little-Piccardi-Lassueur syndrome
HGNC:4947UniProt:P01903
SNRPESmall nuclear ribonucleoprotein EDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome (PubMed:11991638, PubMed:18984161, PubMed:19325628, PubMed:23246290, PubMed:23333303, PubMed:25555158, PubMed:26912367, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:32494006). Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes (PubMed:11991638, PubMed:28076346, PubMed

LOCALIZAÇÃO

Cytoplasm, cytosolNucleus

VIAS BIOLÓGICAS (2)
snRNP AssemblySARS-CoV-2 modulates host translation machinery
MECANISMO DE DOENÇA

Hypotrichosis 11

A form of hypotrichosis, a condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The extent of scalp and body hair involvement can be very variable, within as well as between families. HYPT11 is an autosomal dominant form characterized by scanty or absent eyebrows and a highly variable degree of alopecia since birth, ranging from slight thinning of scalp and axillary hair to complete loss of scalp and body hair. Pubic hair remains mainly unaffected.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
158.7 TPM
Fibroblastos
125.3 TPM
Ovário
89.3 TPM
Cervix Endocervix
82.1 TPM
Cervix Ectocervix
72.5 TPM
OUTRAS DOENÇAS (2)
hypotrichosis 11hypotrichosis simplex
HGNC:11161UniProt:P62304
APCDD1Protein APCDD1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Negative regulator of the Wnt signaling pathway. Inhibits Wnt signaling in a cell-autonomous manner and functions upstream of beta-catenin. May act via its interaction with Wnt and LRP proteins. May play a role in colorectal tumorigenesis

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Hypotrichosis 1

A rare form of non-syndromic hereditary hypotrichosis without characteristic hair shaft anomalies. Affected individuals typically show normal hair at birth, but hair loss and thinning of the hair shaft start during early childhood and progress with age. HYPT1 inheritance is autosomal dominant.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
hypotrichosis 1hypotrichosis simplex
HGNC:15718UniProt:Q8J025
DSG4Desmoglein-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (By similarity). Coordinates the transition from proliferation to differentiation in hair follicle keratinocytes (By similarity). Plays a role in moderating lymphocyte migration to inflamed skin and maintaining homeostasis of the epidermal inflammatory response (By similarity)

LOCALIZAÇÃO

Cell membraneCell junction, desmosome

VIAS BIOLÓGICAS (1)
Formation of the cornified envelope
MECANISMO DE DOENÇA

Hypotrichosis 6

A condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The disorder affects the trunk and extremities as well as the scalp, and the eyebrows and eyelashes may also be involved, whereas beard, pubic, and axillary hairs are largely spared. In addition, patients can develop hyperkeratotic follicular papules, erythema, and pruritus in affected areas. In some patients with congenital hypotrichosis, monilethrix-like hairs showing elliptical nodes have been observed. HYPT6 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.6 TPM
Esôfago - Mucosa
0.5 TPM
Vagina
0.5 TPM
Skin Not Sun Exposed Suprapubic
0.3 TPM
Skin Sun Exposed Lower leg
0.2 TPM
OUTRAS DOENÇAS (3)
hypotrichosis 6monilethrixhypotrichosis simplex
HGNC:21307UniProt:Q86SJ6
KRT74Keratin, type II cytoskeletal 74Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Has a role in hair formation. Specific component of keratin intermediate filaments in the inner root sheath (IRS) of the hair follicle (Probable)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
KeratinizationFormation of the cornified envelope
MECANISMO DE DOENÇA

Woolly hair autosomal dominant

A hair shaft disorder characterized by fine and tightly curled hair. Compared to normal curly hair that is observed in some populations, woolly hair grows slowly and stops growing after a few inches. Under light microscopy, woolly hair shows some structural anomalies, including trichorrhexis nodosa and tapered ends.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.7 TPM
Skin Sun Exposed Lower leg
1.3 TPM
Skin Not Sun Exposed Suprapubic
1.1 TPM
Esôfago - Mucosa
0.5 TPM
Brain Spinal cord cervical c-1
0.4 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (6)
autosomal dominant wooly hairhypotrichosis 3ectodermal dysplasia 7, hair/nail typepure hair and nail ectodermal dysplasia
HGNC:28929UniProt:Q7RTS7
HRLysine-specific demethylase hairlessDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Histone demethylase that specifically demethylates both mono- and dimethylated 'Lys-9' of histone H3. May act as a transcription regulator controlling hair biology (via targeting of collagens), neural activity, and cell cycle

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
Regulation of lipid metabolism by PPARalphaCytoprotection by HMOX1PPARA activates gene expression
MECANISMO DE DOENÇA

Alopecia universalis congenita

A rare disorder characterized by loss of hair from the entire body. No hair are present in hair follicles on skin biopsy.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
102.2 TPM
Skin Sun Exposed Lower leg
94.6 TPM
Cerebelo
66.2 TPM
Cérebro - Hemisfério cerebelar
57.0 TPM
Esôfago - Mucosa
31.6 TPM
OUTRAS DOENÇAS (3)
atrichia with papular lesionsalopecia universalis congenitaMarie Unna hereditary hypotrichosis
HGNC:5172UniProt:O43593
PPP1CBSerine/threonine-protein phosphatase PP1-beta catalytic subunitDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structu

LOCALIZAÇÃO

CytoplasmNucleusNucleus, nucleoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (10)
Downregulation of TGF-beta receptor signalingPhosphorylation and nuclear translocation of the CRY:PER:kinase complexTriglyceride catabolismRAF activationSHOC2 M1731 mutant abolishes MRAS complex function
MECANISMO DE DOENÇA

Noonan syndrome-like disorder with loose anagen hair 2

A syndrome characterized by Noonan dysmorphic features such as macrocephaly, high forehead, hypertelorism, palpebral ptosis, low-set and posteriorly rotated ears, short and webbed neck, pectus anomalies, in association with pluckable, sparse, thin and slow-growing hair.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
334.6 TPM
Aorta
313.4 TPM
Esôfago - Muscular
306.9 TPM
Esôfago - Junção
269.4 TPM
Artéria coronária
234.0 TPM
OUTRAS DOENÇAS (3)
Noonan syndrome-like disorder with loose anagen hair 2RASopathyNoonan syndrome-like disorder with loose anagen hair
HGNC:9282UniProt:P62140
CDSNCorneodesmosinDisease-causing germline mutation(s) inModerado
FUNÇÃO

Important for the epidermal barrier integrity

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Formation of the cornified envelope
MECANISMO DE DOENÇA

Hypotrichosis 2

A condition characterized by the presence of less than the normal amount of hair. Affected individuals have normal hair in early childhood but experience progressive hair loss limited to the scalp beginning in the middle of the first decade and almost complete baldness by the third decade. Body hair, beard, eyebrows, axillary hair, teeth, and nails develop normally. HYPT2 inheritance is autosomal dominant.

OUTRAS DOENÇAS (3)
hypotrichosis 2peeling skin syndrome 1hypotrichosis simplex of the scalp
HGNC:1802UniProt:Q15517

Medicamentos e terapias

MINOXIDILPhase 4

Mecanismo: Sulfonylurea receptor 2, Kir6.2 opener

RITLECITINIB TOSYLATEPhase 4

Mecanismo: TEC family kinase inhibitor

FINASTERIDEPhase 4

Mecanismo: Steroid 5-alpha-reductase 2 inhibitor

BIMATOPROSTPhase 4

Mecanismo: Prostanoid FP receptor agonist

CLASCOTERONEPhase 3

Mecanismo: Androgen Receptor antagonist

RUXOLITINIBPhase 3

Mecanismo: Tyrosine-protein kinase JAK2 inhibitor

UPADACITINIBPhase 3

Mecanismo: Tyrosine-protein kinase JAK2 inhibitor

HYDROCORTISONEPhase 3

Mecanismo: Glucocorticoid receptor agonist

RITLECITINIBPhase 3

Mecanismo: TEC family kinase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

287 variantes patogênicas registradas no ClinVar.

🧬 RPL21: GRCh37/hg19 13q11-31.3(chr13:19436287-92292639)x3 ()
🧬 RPL21: GRCh37/hg19 13q11-34(chr13:19253848-115108937)x3 ()
🧬 RPL21: GRCh37/hg19 13p13-q34(chr13:1-115169878) ()
🧬 RPL21: GRCh37/hg19 13q11-34(chr13:19436286-115107733) ()
🧬 RPL21: GRCh37/hg19 13q11-34(chr13:19436286-114981726) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,337 variantes classificadas pelo ClinVar.

869
468
VUS (65.0%)
Benigna (35.0%)
VARIANTES MAIS SIGNIFICATIVAS
FOXN1: NM_001369369.1(FOXN1):c.330C>A (p.Ser110Arg) [Uncertain significance]
FOXN1: NM_001369369.1(FOXN1):c.1781C>G (p.Ala594Gly) [Uncertain significance]
GJA1: NM_000165.5(GJA1):c.488C>G (p.Ser163Cys) [Uncertain significance]
FOXN1: NM_001369369.1(FOXN1):c.1531C>A (p.Pro511Thr) [Uncertain significance]
FOXN1: NM_001369369.1(FOXN1):c.777G>C (p.Gln259His) [Uncertain significance]

Vias biológicas (Reactome)

60 vias biológicas associadas aos genes desta condição.

L13a-mediated translational silencing of Ceruloplasmin expression Peptide chain elongation SRP-dependent cotranslational protein targeting to membrane Viral mRNA Translation Selenocysteine synthesis Major pathway of rRNA processing in the nucleolus and cytosol Formation of a pool of free 40S subunits GTP hydrolysis and joining of the 60S ribosomal subunit Eukaryotic Translation Termination Regulation of expression of SLITs and ROBOs Response of EIF2AK4 (GCN2) to amino acid deficiency Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA G alpha (q) signalling events P2Y receptors Activation of gene expression by SREBF (SREBP) Lanosterol biosynthesis RAF activation SHOC2 M1731 mutant abolishes MRAS complex function Gain-of-function MRAS complexes activate RAF signaling Synthesis of PA Keratinization Formation of the cornified envelope Downstream TCR signaling Phosphorylation of CD3 and TCR zeta chains Translocation of ZAP-70 to Immunological synapse Generation of second messenger molecules MHC class II antigen presentation Co-inhibition by PD-1 Interferon gamma signaling SLBP independent Processing of Histone Pre-mRNAs snRNP Assembly mRNA Splicing - Major Pathway mRNA Splicing - Minor Pathway RNA Polymerase II Transcription Termination SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs SARS-CoV-2 modulates host translation machinery mRNA Polyadenylation Dengue Virus-Host Interactions RHO GTPases activate PKNs RHO GTPase Effectors Transcriptional regulation of pluripotent stem cells PTEN Regulation Regulation of PTEN gene transcription Downregulation of SMAD2/3:SMAD4 transcriptional activity TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) Complement cascade Drug-mediated inhibition of ERBB2 signaling MET Receptor Activation Triglyceride catabolism Downregulation of TGF-beta receptor signaling Regulation of PLK1 Activity at G2/M Transition RHO GTPases activate CIT RHO GTPases Activate ROCKs RHO GTPases activate PAKs Maturation of hRSV A proteins Phosphorylation and nuclear translocation of the CRY:PER:kinase complex

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado5
3Fase 311
2Fase 26
1Fase 11
·Pré-clínico6
Medicamentos catalogadosEnsaios clínicos· 9 medicamentos · 20 ensaios
✓ Aprovados — podem ser usados hoje
MINOXIDILRITLECITINIB TOSYLATEFINASTERIDEBIMATOPROST
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alopecia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

16 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

689 ensaios clínicos encontrados, 36 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
12.896 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 12.896

#1

Frequency and associated factors of herpes zoster infection in SLE patients from Latin America: data from the GLADEL 2.0 cohort.

Lupus science & medicine2026 Mar 23

Este estudo revelou uma alta incidência de Herpes Zoster (HZ) em pacientes latino-americanos com Lúpus Eritematoso Sistêmico (LES), sendo uma preocupação significativa. A ocorrência de HZ está associada a maior atividade da doença, uso de altas doses de prednisona, manifestações neuropsiquiátricas como psicose e convulsões, e também foi observada maior frequência de **alopecia** nesses pacientes. Para pacientes e médicos, é crucial estar atento: mulheres, doença mais ativa e uso de prednisona são preditores independentes de HZ, o que exige uma estratificação de risco proativa e vigilância, especialmente em pacientes com lúpus mais grave ou em terapia com corticoides.

🇧🇷 traduzido
#2

An updated guide to hair follicle stem cell markers and changes in their expression with aging.

JID innovations : skin science from molecules to population health2026 May

Este artigo científico oferece um guia atualizado sobre os marcadores das células-tronco do folículo piloso (HFSCs), essenciais para sua identificação e manipulação. Para pacientes e médicos, compreender esses marcadores é crucial para o desenvolvimento de novas terapias e a regeneração capilar em casos de alopecia, inclusive considerando as mudanças na expressão desses marcadores com o envelhecimento.

🇧🇷 traduzido
#3

Trusting your gut: a hairy situation-gastric trichobezoar case report.

Frontiers in pediatrics2026

Este artigo descreve um tricobezoar gástrico, uma massa rara de cabelo ingerido, comum em meninas jovens, que pode causar dor abdominal e perda de peso, frequentemente confundidos com outras condições. O diagnóstico é desafiador e pode ser tardio, especialmente na ausência de alopecia visível ou histórico psiquiátrico, pois exames iniciais são frequentemente inconclusivos. Para pacientes e médicos, é crucial considerar o tricobezoar no diagnóstico diferencial de sintomas abdominais inespecíficos em crianças, sendo a endoscopia digestiva alta (EDA) fundamental para a confirmação.

🇧🇷 traduzido
#4

Pharmacokinetics and Analgesic Efficacy of a Novel Extended-Release Buprenorphine Formulation in Mice.

Journal of the American Association for Laboratory Animal Science : JAALAS2026 Mar 01

Este artigo descreve a avaliação de uma nova formulação de buprenorfina de liberação prolongada (Bup ER) em camundongos, que demonstrou proporcionar analgesia pós-operatória eficaz por 48 a 96 horas com uma única dose, mantendo níveis plasmáticos do medicamento por até 120 horas. Para pacientes e médicos, isso sugere um potencial para um manejo da dor prolongado e menos frequente. Os efeitos adversos foram geralmente leves e locais, como vermelhidão ou alopecia (perda de pelo) no local da injeção, sendo que lesões mais graves foram atribuídas à técnica de aplicação e não ao medicamento em si.

🇧🇷 traduzido
#5

Combined itraconazole and terbinafine therapy for pediatric kerion: a report of two cases.

Translational pediatrics2026 Feb 28

Este artigo relata dois casos de quério pediátrico (uma infecção fúngica do couro cabeludo que causa massas purulentas e alopecia), destacando que a condição é frequentemente mal diagnosticada como infecção bacteriana devido à sua raridade, resultando em atrasos e tratamentos iniciais ineficazes. Os casos demonstraram, no entanto, que após um diagnóstico etiológico correto, a terapia antifúngica combinada com itraconazol e terbinafina é altamente eficaz, levando à resolução completa. Isso enfatiza a importância crucial de médicos considerarem etiologias fúngicas em lesões purulentas do couro cabeludo em crianças e buscarem testes específicos para garantir um tratamento precoce e bem-sucedido.

🇧🇷 traduzido

Publicações recentes

Ver todas no PubMed

📚 EuropePMC12.606 artigos no totalmostrando 195

2026

Effectiveness and Safety of Topical Finasteride for Male Androgenetic Alopecia: Real World Data.

International journal of dermatology
2026

Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.

European journal of dermatology : EJD
2026

Frequency and associated factors of herpes zoster infection in SLE patients from Latin America: data from the GLADEL 2.0 cohort.

Lupus science & medicine
2026

Sustained Remission of Alopecia Areata Universalis following Red Cell Transfusion.

Irish medical journal
2026

Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma - Multifaceted Control.

Clinical, cosmetic and investigational dermatology
2026

Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis.

Clinical, cosmetic and investigational dermatology
2026

Chemotherapy and the Skin: Understanding Dermatologic Side Effects.

Cureus
2026

Chemotherapy-Induced Toxicities in Pediatric Cancer Patients: A Cross-Sectional Survey Using a Child- and Caregiver-Reported Outcome Tool in Tanzania.

Drug, healthcare and patient safety
2026

Bilateral ovarian steroid cell tumor in a postmenopausal woman with progressive hyperandrogenism.

JCEM case reports
2026

Transient Neonatal Zinc Deficiency due to Maternal Variants in SLC30A2: An Emerging and Atypical Candidate Gene for Maternal Carrier Screening.

American journal of medical genetics. Part A
2026

Post-finasteride syndrome: survey of dermatologists from the Spanish Hair and Nail Disorders Group.

Actas dermo-sifiliograficas
2026

Ethical Considerations of Excusing Students With Alopecia Areata From Physical Education Activities.

Journal of the American Academy of Dermatology
2026

Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study.

Journal of the American Academy of Dermatology
2026

Effective treatment of alopecia areata and psoriasis with baricitinib.

The British journal of dermatology
2026

Real-World Evidence of Baricitinib in Severe Alopecia Areata: Insights From a Spanish Case Series.

Actas dermo-sifiliograficas
2026

Recombinant Filaggrin-2 microneedles reverse androgenetic alopecia by rescuing mitochondrial dysfunction in dermal papilla cells.

International journal of biological macromolecules
2026

Acupuncture for treating alopecia areata: A systematic review and meta-analysis.

Medicine
2026

A rare variant of lichen planopilaris: Familial Graham-Little-Piccardi-Lassueur syndrome in Saudi Arabia.

JAAD case reports
2026

Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment - A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp.

Clinical, cosmetic and investigational dermatology
2026

Early-onset recipient-site necrosis after FUE hair transplantation complicated by Pseudomonas aeruginosa infection: a case report.

Journal of surgical case reports
2026

Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study.

JAAD international
2026

Finesse in Forehead Lifting-Asymmetric Ligament Release for Asymmetric Brow Ptosis.

Aesthetic plastic surgery
2026

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study.

Veterinary dermatology
2026

S3 guideline diagnostics and therapy of alopecia areata - Part 1: Diagnostics and epidemiology.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2026

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

American journal of clinical dermatology
2026

Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications.

Dermatology and therapy
2026

An updated guide to hair follicle stem cell markers and changes in their expression with aging.

JID innovations : skin science from molecules to population health
2026

Addisonian Crisis in a 39-Year-Old Woman With Primary Adrenal Insufficiency.

Cureus
2026

Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions.

ADMET & DMPK
2026

Convergent Regenerative Strategies in PM&R for Musculoskeletal and Hair Restoration: Integration of PRP, Exosomes, and Physical Modalities.

Archives of internal medicine research
2026

Clinical, Histopathological and Epidemiological Features of Dorsal Melanotrichia of Poodles and Poodle Crosses.

Veterinary dermatology
2026

The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial.

Scientific reports
2026

Comorbidities in Discoid Lupus: A Systematic Review and Meta-analysis of Prevalence and Association.

Dermatology and therapy
2026

Skin bacteriota ameliorates androgenetic alopecia via harmonizing skin immuno inflammatory balance.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
2026

Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.

Annals of plastic surgery
2026

Frontal fibrosing alopecia and lichen planopilaris: epidemiology, treatment, and remission rate (2014-2024).

Dermatology reports
2026

Management of classic lichen planopilaris: The EADV task force on hair diseases position statement.

Journal of the European Academy of Dermatology and Venereology : JEADV
2026

Treatment Outcomes of Lipedematous Scalp and Lipedematous Alopecia: A Systematic Review.

International journal of dermatology
2026

Scalp Alopecia After Greater Occipital Nerve Block Administration Mimicking Alopecia Areata.

The American Journal of dermatopathology
2025

Effect of Palliative Treatment and Viddhakarma (Puncture Therapy in Ayurveda) in an Androgenetic Alopecia (Khalitya)-A Case Report.

Journal of pharmacy & bioallied sciences
2026

[Discussion on the treatment of seborrheic alopecia with acupuncture and moxibustion based on the theory of zhuoxie haiqing].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion
2026

Trusting your gut: a hairy situation-gastric trichobezoar case report.

Frontiers in pediatrics
2026

Gastrointestinal bezoars: two distinct cases illustrating diagnostic and surgical challenges.

International journal of surgery case reports
2026

Clinical, trichoscopic, and histological characteristics of 46 hispanic men with fibrosing alopecia in a pattern distribution: a retrospective multicenter analysis.

Frontiers in medicine
2026

Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study.

Frontiers in medicine
2026

The Early Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients with Early Breast Cancer.

ClinicoEconomics and outcomes research : CEOR
2026

The brain-gut-skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies.

Frontiers in immunology
2026

Nanoparticle albumin-bound paclitaxel -induced severe interstitial lung disease in a gastric cancer patient: a case report.

Frontiers in oncology
2026

A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor-Hair Serum for the Prevention of Chemotherapy-Induced Alopecia.

Journal of cosmetic dermatology
2026

UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune-Mediated Inflammatory Diseases.

Photodermatology, photoimmunology & photomedicine
2026

Post-marketing safety of CGRP monoclonal antibodies and gepants: A systematic review of spontaneous reporting system data.

Headache
2026

Pharmacokinetics and Analgesic Efficacy of a Novel Extended-Release Buprenorphine Formulation in Mice.

Journal of the American Association for Laboratory Animal Science : JAALAS
2026

Prescribing Habits for Androgenetic Alopecia among Dermatologists in Spain in 2024: A Cross-Sectional Study.

Actas dermo-sifiliograficas
2026

Real-World Safety of JAK Inhibitors in Skin Immune-Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study.

Clinical pharmacology and therapeutics
2026

Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss.

Cancers
2026

Advances in Medicalized Hair Loss Solutions: A Review of Current Clinical Practices and Regenerative Medicine-Based Protocols with Focus on Off-Label Injectable Treatments.

Journal of clinical medicine
2026

Alopecia after GLP-1 agonist therapy: A TriNetX Database active comparator retrospective cohort study.

Journal of the American Academy of Dermatology
2026

Deletion of vitamin D receptor with calcium sensing receptor in keratinocytes promotes epidermal tumorigenesis by limiting dna repair and oxidative stress response genes.

The Journal of steroid biochemistry and molecular biology
2026

Non-Invasive Scalp Tape-Strip RNA Sequencing Captures Disease Activity and Treatment-Response Signatures in Alopecia Areata.

Allergy
2026

Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.

International journal of dermatology
2026

Use of Castor Oil in Dermatology: A Narrative Review.

Cureus
2026

Oxidative Stress and Hormone-Regulated Dermal Papilla Cell-Targeted Nanomodulators: Reverse Cellular Senescence for Androgenetic Alopecia Therapy.

Biomaterials research
2026

Bioorthogonal Click-Engineered Microneedle Patch Enables Adeno-Associated Virus-Mediated Dermal Acidic Fibroblast Growth Factor Expression for Hair Loss Treatment.

ACS nano
2026

Ferulic acid promotes hair growth via estrogen receptor alpha activation in cultured human dermal papilla cells.

Scientific reports
2026

Lactiplantibacillus plantarum ZJUIDS51 improves androgenic alopecia via gut-skin axis.

Food research international (Ottawa, Ont.)
2026

Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.

The Journal of the Association of Physicians of India
2026

Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era.

Frontiers in medicine
2026

Case Report: PTCH1 splice-site mutation and sonidegib treatment in Gorlin-Goltz syndrome: clinical insights from a family case study.

Frontiers in medicine
2026

Pruritus in Hemodialysis Patients in a Sub-Saharan African Country: Benin-Associated Skin Conditions and Other Factors in 2023 in Three Hemodialysis Centers.

Dermatology research and practice
2026

Real-World Efficacy of Ritlecitinib in Adolescent Patients With Alopecia Areata: A 36 Week Monocentric Real-Life Observational Study.

Journal of cutaneous medicine and surgery
2026

Sequential Small-Molecule Therapy for Lymphocytic Cicatricial Alopecia: A Multicenter Prospective Cohort Pilot Study.

Journal of the American Academy of Dermatology
2026

Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology).

Actas dermo-sifiliograficas
2026

Presentations of Cutaneous Disease in Various Skin Pigmentations: Keratosis Pilaris.

HCA healthcare journal of medicine
2026

Combined itraconazole and terbinafine therapy for pediatric kerion: a report of two cases.

Translational pediatrics
2026

Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database.

Frontiers in immunology
2026

Revisiting Contact Sensitization Among Patients With LPP/FFA: Cross-Sectional Findings From 55 Cases.

Dermatitis : contact, atopic, occupational, drug
2026

Clinical and Immunological Profiles With Treatment Patterns in Systemic Lupus Erythematosus Patients in the Eastern Part of India: A Retrospective, Hospital-Based, Cross-Sectional Study.

Cureus
2026

Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan.

The Journal of dermatology
2026

The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients' perspectives to guide therapy.

Clinical and experimental dermatology
2026

Generative Artificial Intelligence Tools: Evaluating Ways to Automate Your SALT (GATEWAYS) Scoring of Alopecia Areata.

Pediatric dermatology
2026

Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA.

Dermatology and therapy
2026

Unravelling the threads of central centrifugal cicatricial alopecia.

The Journal of investigative dermatology
2026

Nanozyme Catalysis Restores Hair Follicle Integrity by Reversing Peroxisomal Collapse.

ACS nano
2026

Alopecia Areata in a Patient Undergoing Treatment for Secondary Syphilis: A Diagnostic Challenge.

Cureus
2026

Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review.

Cureus
2026

First-Line Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Extensive-Stage SCLC: A Long-Term Survival and PD-L1 Subgroup Analysis From the Randomized, Phase 3 RATIONALE-312 Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2026

Recurrent Male Hydrops Fetalis Reveals Hidden Incontinentia Pigmenti: Lessons From Pseudogene-Interfered Genomic Diagnosis.

Prenatal diagnosis
2026

Hormonal Contraceptives: Part II- Use and Relevance in Clinical Dermatology.

Journal of the American Academy of Dermatology
2026

Insurance-Driven Switching and Real-World Treatment Outcomes of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study.

Journal of the American Academy of Dermatology
2026

Serum ferritin and hair iron content in correlation to hair diameter and density: a case-control study.

Dermatology reports
2026

Clinical and trichoscopic features of early congenital syphilis: a single-center cross-sectional study.

Frontiers in medicine
2026

Alterations of white matter connectivity in alopecia areata patients.

Brain imaging and behavior
2026

Skin Commensal Microbiota Does Not Influence the Clinical Course of Dermatophyte Infection in Persian Cats.

Veterinary dermatology
2026

Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study.

Journal of the American Academy of Dermatology
2026

Global, regional, and national burden of alopecia areata in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis.

Frontiers in public health
2026

Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review.

Frontiers in immunology
2026

Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern hair loss in hair transplant patients using a modified Delphi process.

Expert opinion on pharmacotherapy
2026

Highlights from JAAD Case Reports: May 2026.

Journal of the American Academy of Dermatology
2026

Exploring novel management options for alopecia areata.

The American journal of managed care
2026

Recyclable Polymerizable Deep Eutectic Solvent-Based Three-Dimensional-Printed Dissolving Microneedles with pH-Responsive Delivery of ZIF-8-Loaded Minoxidil for Hair Loss Therapy.

ACS applied materials & interfaces
2026

Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I - Nonscarring Disorders.

Journal of drugs in dermatology : JDD
2026

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata.

Journal of drugs in dermatology : JDD
2026

Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series.

Journal of drugs in dermatology : JDD
2026

Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review.

Journal of drugs in dermatology : JDD
2026

Emerging Therapeutic Strategies in Central Centrifugal Cicatricial Alopecia: A Review of the Clinical Trial Landscape.

Journal of drugs in dermatology : JDD
2026

From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy.

Journal of drugs in dermatology : JDD
2026

Regrowth of Eyebrows in a Previous Steroid Non-Responder With Alopecia Universalis After Ritlecitinib Treatment.

Journal of drugs in dermatology : JDD
2026

Baricitinib-Related Adverse Events in Alopecia Areata and Rheumatoid Arthritis: A Comparative Study.

Journal of drugs in dermatology : JDD
2026

Patient Perspectives and Attitudes Toward the Diagnostic Process for Central Centrifugal Cicatricial Alopecia.

Journal of drugs in dermatology : JDD
2026

Targeting Endogenous Wnt Antagonists for Therapy Development in AGA: a Focus on DKKs and sFRPs.

Stem cell reviews and reports
2026

Development of a Visual Extension of the Severity of Alopecia Tool (VESALT) for Alopecia Areata.

Journal of the European Academy of Dermatology and Venereology : JEADV
2026

Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study.

Cancer diagnosis & prognosis
2026

Beard hair response in alopecia areata universalis treated with baricitinib.

JAAD international
2026

Dermatologists' Perspectives and Real-World Assessment of Alopecia Areata Severity in Adults in Taiwan: A Cross-sectional Survey.

Dermatology and therapy
2026

Pediatric Radiation-Induced Alopecia Post Intracranial Vascular Malformation Embolization: A Case Report with Dermoscopic Findings.

Clinical, cosmetic and investigational dermatology
2026

Indirect Exposure to Topical Minoxidil Causing Generalized Hypertrichosis in Children: A Report of Two Cases.

International journal of dermatology
2026

Female pattern hair loss.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
2026

A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Ashwagandha Root Extract Capsule on Skin and Hair Health in Healthy Adults.

Phytotherapy research : PTR
2026

Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies.

Frontiers in pharmacology
2026

A real-world study of ublituximab based on the WHO-VigiAccess and U.S. food and drug administration's adverse event reporting system databases.

Frontiers in immunology
2026

Finasteride-Loaded Phospholipid-Bile Salt Mixed Micelles for Targeted Follicular Delivery in Androgenetic Alopecia.

Journal of drug targeting
2026

Subsequent development of immune-mediated inflammatory diseases in patients with new-onset alopecia areata: An age-and sex-stratified cohort study using TriNetX.

Journal of the American Academy of Dermatology
2026

A comprehensive literature-based analysis of prognosis in patients with Cronkhite-Canada syndrome.

Digestion
2026

Phytochemical Profiling of the Halophyte Artemisia fukudo Makino and Its In Vitro Effects on Androgen-Related Pathways Associated With Benign Prostatic Hyperplasia and Alopecia.

ChemistryOpen
2026

Finasteride withdrawal induces anxiety-like behavior and novelty avoidance in adult male rats.

Journal of neuroendocrinology
2026

Artificial Intelligence in Hair Disorders: A Narrative Review.

Dermatology and therapy
2026

A prospective study of hair transplantation combined with concentrated growth factors for the treatment of androgenetic alopecia.

The Journal of dermatological treatment
2026

Coexistence of Friedreich's Ataxia and Esophageal Cancer: A Case Report.

Clinical case reports
2026

Direct No-Shave Follicular Unit Excision (DNS FUE): A Modified Technique and Case Series.

Cureus
2026

A Small-Molecule SLD1121 Activates Wnt/β-Catenin Signaling and Promotes Hair Growth via Targeting the Wnt Coreceptor LRP6.

JACS Au
2026

Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness.

International journal of molecular sciences
2026

Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.

Genes
2026

Off-Label Treatment of Alopecia Areata-Retrospective Study.

Biomedicines
2026

Exosome-Based Therapeutics in Dermatology and Beyond: A Narrative Review.

Biomedicines
2026

Weight Loss-Associated Alopecia Areata.

American journal of therapeutics
2026

Single-cell transcriptomics reveals hair growth retardation mediated by aberrant connective tissue sheath contraction in male androgenetic alopecia.

Nature communications
2026

Disparities in adverse event perception between patients and healthcare providers in gynaecologic anticancer therapy: results from an observational web-based study in Japan.

BMJ open
2026

Hair morphology: An overlooked variable in alopecia drug trials.

Journal of the American Academy of Dermatology
2026

Associated comorbidities in pediatric patients with alopecia areata.

Boletin medico del Hospital Infantil de Mexico
2026

Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy.

Clinics and practice
2026

The Double-Edged Effect of Chronic Corticosteroid Use in Scarring Alopecia: A Call for Further Investigation.

International journal of dermatology
2026

Safety assessment of frunevetmab for osteoarthritis pain in cats: disproportionality analysis of the Food and Drug Administration Animal Drug Adverse Events database.

Journal of veterinary internal medicine
2026

Community Outreach for Hair Loss Education: A Pilot Feasibility Study.

International journal of dermatology
2026

Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss.

The Journal of dermatological treatment
2026

Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata.

The Journal of allergy and clinical immunology
2026

Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey.

Immunity, inflammation and disease
2026

Alopecia Areata - Effects of Treatment with Upadacitinib - Two Case Reports.

Clinical, cosmetic and investigational dermatology
2026

Diagnostic Performance of the Trichogram Compared to Histopathology of Scalp Biopsy in Horizontal Sections in Female Androgenetic Alopecia: A Retrospective Study.

Skin appendage disorders
2026

Immune Microenvironment of Hair Follicles in Tumor Immunotherapy.

ImmunoTargets and therapy
2026

Late Onset Telomere Biology Disorder Presenting With Pancytopenia, Immune Dysregulation, Interstitial Lung Disease and Alopecia.

American journal of hematology
2026

Herpes Zoster Recurrence With Disease Remission Under JAK Inhibition for Alopecia Areata: Balancing Two Side of Immune Memory.

The Journal of dermatology
2026

Risk for attention deficit hyperactivity disorder in alopecia areata patients: A nationwide case-control study.

Annales de dermatologie et de venereologie
2026

Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study.

Clinical drug investigation
2026

Poly‑D,L‑lactic acid (PDLLA) scalp microinjection protocol with optional light microneedling priming for non‑scarring alopecia: A prospective pilot case series.

JPRAS open
2026

Exosomes in Skin of Color: Dermatological Insights, Therapeutic Potential, and Clinical Realities in India.

Cureus
2026

Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from China.

Lupus science & medicine
2026

Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications.

Journal of the American Academy of Dermatology
2026

Rapunzel Syndrome in a Pediatric Female Patient: A Case Report of Trichobezoar Causing Intestinal Obstruction.

Cureus
2026

Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody-drug conjugate in breast cancer.

Oncology reviews
2026

Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model.

International journal of nanomedicine
2026

Associations of Lichen Sclerosus With Autoimmune Diseases: A Systematic Review and Meta-Analysis.

BJOG : an international journal of obstetrics and gynaecology
2026

Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Study.

Dermatology and therapy
2026

Visit complexity differs between scarring and nonscarring alopecia: A 5-year DataDerm analysis.

Journal of the American Academy of Dermatology
2026

ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata.

Journal of nanobiotechnology
2026

5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes.

NeuroSci
2026

Lifestyle factors affecting the pathogenesis of androgenetic alopecia: a literature review.

Frontiers in public health
2026

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.

American journal of clinical dermatology
2026

Impact of GLP-1 and GLP-1/GIP agonists on healthcare resource utilization in individuals with scarring alopecias: A retrospective cohort analysis using TriNetX.

Journal of the American Academy of Dermatology
2026

Publisher's Note: British Association of Dermatologists living guideline for managing people with alopecia areata 2024.

The British journal of dermatology
2026

Early-Onset Trichotillomania With Predominantly Other-Directed Trichophagia in a 23-Month-Old Girl: A CARE-Compliant Case Report.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
2026

Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial.

Therapeutic advances in medical oncology
2026

Oral Tofacitinib for Refractory Lichen Planus Pigmentosus Coexisting with Frontal Fibrosing Alopecia.

Indian dermatology online journal
2026

The extract of Cyperus rotundus rhizome promotes hair growth and modulates hair cycle in vivo and in vitro.

Chinese journal of natural medicines
2026

Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study.

Journal of the American Academy of Dermatology
2026

Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia.

Probiotics and antimicrobial proteins
2026

Histological and Trichographic Differences Between Coat Types in Non-Alopecic Pomeranians and With Alopecia X.

Veterinary dermatology
2026

Effect of Platelet-Rich Plasma on Hair Follicle Growth in C57BL/6 Mice.

Aesthetic plastic surgery
2026

Cinnamomum burmannii Leaves-Derived Carbon Dots Promote Angiogenesis and Stimulate Hair Follicle Regeneration by Reshaping the Microenvironment of Hair Follicles.

ACS applied materials & interfaces
2026

Radiation-Induced Alopecia in Patients Undergoing Intracranial Radiotherapy: A Systematic Review.

International journal of radiation oncology, biology, physics
2026

EXPRESS: Carbon dioxide laser ablation as an alternative or adjunct treatment of Bowenoid in situ carcinoma (BISC) in five cats.

Journal of feline medicine and surgery
2026

The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden.

Acta dermato-venereologica
2026

Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations.

International journal of dermatology
2026

JAAD CME Part 2: Clinical Evidence and Safety Considerations for GLP-1 Receptor Agonists in Dermatology.

Journal of the American Academy of Dermatology
2025

Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations.

Frontiers in pharmacology
2026

SALT Score Cards: Facilitating SALT Score Calculation in Alopecia Areata.

The Australasian journal of dermatology
2026

Elucidating the Role of Vitamin D Receptor (VDR) Polymorphisms in Genetic Susceptibility to Systemic Lupus Erythematosus: A Case-Control Study From Western India.

International journal of immunogenetics
2026

Hair follicle-targeted baicalin nanocrystal delivery using microneedles for long-acting treatment of androgenetic alopecia.

International journal of pharmaceutics
2026

Managing Skin Diseases that Flare During Pregnancy and in the Postpartum period: Part 2- Management & Safety Considerations.

Journal of the American Academy of Dermatology
2026

Vitamins and hair: Sham or science?

Clinics in dermatology
2026

Line-Field Confocal OCT in Primary Cicatricial Alopecias: Enabling Precision Diagnosis and Clinical Decision Support.

International journal of dermatology
2026

Artificial intelligence-enabled precision medicine for inflammatory skin diseases.

The Journal of investigative dermatology
2026

Effective topical delivery of minoxidil via chitosan coated nanocapsules to remodel microenvironment of dermal follicle for hair regeneration.

Drug delivery and translational research
2026

MLPH-mediated activation of dermal papilla IGF-1 signaling drives human hair shaft elongation and anagen induction.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2026

Alopecia as an atypical presentation of Langerhans cell histiocytosis in an adult male.

JAAD case reports
2026

Postpartum-Onset Dermatomyositis Presenting With Malignant Pleural Effusion: A Case Report.

Cureus
Ver todos os 12.606 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alopecia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Alopecia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Frequency and associated factors of herpes zoster infection in SLE patients from Latin America: data from the GLADEL 2.0 cohort.
    Lupus science & medicine· 2026· PMID 41871917mais citado
  2. An updated guide to hair follicle stem cell markers and changes in their expression with aging.
    JID innovations : skin science from molecules to population health· 2026· PMID 41853462mais citado
  3. Trusting your gut: a hairy situation-gastric trichobezoar case report.
    Frontiers in pediatrics· 2026· PMID 41837189mais citado
  4. Pharmacokinetics and Analgesic Efficacy of a Novel Extended-Release Buprenorphine Formulation in Mice.
    Journal of the American Association for Laboratory Animal Science : JAALAS· 2026· PMID 41833307mais citado
  5. Combined itraconazole and terbinafine therapy for pediatric kerion: a report of two cases.
    Translational pediatrics· 2026· PMID 41810182mais citado
  6. A Unique Case of Lupus Erythematosus Profundus Presenting With Localized Scarring Alopecia and Perioral Swelling in a Pediatric Patient.
    Cureus· 2026· PMID 41994712recente
  7. Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report.
    Cureus· 2026· PMID 41993764recente
  8. Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.
    Int J Clin Oncol· 2026· PMID 41989665recente
  9. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach.
    Dermatol Ther (Heidelb)· 2026· PMID 41989657recente
  10. Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia.
    J Am Acad Dermatol· 2026· PMID 41990955recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79364(Orphanet)
  2. MONDO:0004907(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q181391(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alopecia
Compêndio · Raras BR

Alopecia

ORPHA:79364 · MONDO:0004907
CID-11
Ensaios
36 ativos
Medicamentos
9 registrados
MedGen
UMLS
C0002170
Repurposing
3 candidatos
finasteride5 alpha reductase inhibitor
minoxidilKATP activator|Kir6 channel (KATP) activator|vasodilator
promestrieneestrogen receptor agonist
Wikidata
Wikipedia
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades